fosfluconazole has been researched along with Candidiasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Ishiko, J; Kawakami, Y; Nagino, K; Shinkai, K; Sobue, S | 1 |
| Fujinaga, H; Oda, S; Takahashi, K | 1 |
| Iishii, K; Inami, N; Kimura, E; Nomura, S; Urase, F | 1 |
1 review(s) available for fosfluconazole and Candidiasis
| Article | Year |
|---|---|
[Nonclinical studies and clinical studies on fosfluconazole, a triazole antifungal agent (Prodif)].
Topics: Adult; Animals; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Cryptococcosis; Fluconazole; Humans; Injections, Intravenous; Male; Organophosphates; Rats | 2004 |
2 other study(ies) available for fosfluconazole and Candidiasis
| Article | Year |
|---|---|
Infectious myositis involving the piriformis in a patient with rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal; Antifungal Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Humans; Infliximab; Methotrexate; Middle Aged; Muscle, Skeletal; Myositis; Organophosphates; Staphylococcal Infections; Tomography, X-Ray Computed | 2006 |
Elevation of activated platelet-dependent chemokines and soluble cell adhesion molecules in patients with hematologic malignancies and high levels of beta-D-glucan.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; beta-Glucans; Biomarkers; Candidiasis; Cell Adhesion Molecules; Chemokines; Female; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Organophosphates; Platelet Activation; Prodrugs | 2007 |